Search results
Yingli Pharma Announces NMPA Approval of New Anti-cancer Drug Linperlisib
MediaOutReach via Yahoo Singapore Finance· 2 years agoThe first highly selective PI3Kδ inhibitor in ChinaSHANGHAI, CHINA - Media OutReach - 9 November...
The first highly selective PI3Kδ inhibitor in ChinaSHANGHAI, CHINA - Media OutReach - 9 November...